Written Question·Department of Health and Social Care·UIN 87209
Omaveloxolone
Tabled: 3 November 2025
Answered: 11 November 2025
Named DayQuestion
Sir Julian Lewis
Conservative — New Forest East
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a
Answer
Dr Zubir AhmedThe Department has made no assessment of the reasons for the difference in the availability of omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in Scotland, England, and Wales.Decisions on the availability of medicines are taken by the resp...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 87209) →